共 14 条
[1]
Simon R(1984)Importance of prognostic factors in cancer clinical trials Cancer Treat Rep 68 185-192
[2]
Aguayo A(1999)Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia Blood 94 3717-3721
[3]
Estey E(2000)Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB Blood 95 72-77
[4]
Kantarjian H(1994)The dangers of using ‘optimal cutpoints’ in the evaluation of prognostic factors J Natl Cancer Inst 86 829-835
[5]
Estey EH(1999)Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/− all-trans retinoic acid +/− granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome Blood 93 2478-2484
[6]
Shen Y(undefined)undefined undefined undefined undefined-undefined
[7]
Thall PF(undefined)undefined undefined undefined undefined-undefined
[8]
Altman DG(undefined)undefined undefined undefined undefined-undefined
[9]
Lausen B(undefined)undefined undefined undefined undefined-undefined
[10]
Sauerbrei W(undefined)undefined undefined undefined undefined-undefined